Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells.
De Vitis C, Corleone G, Salvati V, Ascenzi F, Pallocca M, De Nicola F, Fanciulli M, di Martino S, Bruschini S, Napoli C, Ricci A, Bassi M, Venuta F, Rendina EA, Ciliberto G, Mancini R. De Vitis C, et al. Among authors: di martino s. J Clin Med. 2019 Nov 9;8(11):1928. doi: 10.3390/jcm8111928. J Clin Med. 2019. PMID: 31717588 Free PMC article.
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
Bruschini S, di Martino S, Pisanu ME, Fattore L, De Vitis C, Laquintana V, Buglioni S, Tabbì E, Cerri A, Visca P, Alessandrini G, Facciolo F, Napoli C, Trombetta M, Santoro A, Crescenzi A, Ciliberto G, Mancini R. Bruschini S, et al. Among authors: di martino s. J Cell Physiol. 2020 Mar;235(3):1877-1887. doi: 10.1002/jcp.29121. Epub 2019 Aug 9. J Cell Physiol. 2020. PMID: 31397494 Free PMC article.
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.
Marchesi F, Pimpinelli F, Sperandio E, Papa E, Falcucci P, Pontone M, di Martino S, de Latouliere L, Orlandi G, Morrone A, Ciliberto G, Mengarelli A; I.F.O.-COVID-19-Team. Marchesi F, et al. Among authors: di martino s. Br J Haematol. 2022 Jan;196(2):362-367. doi: 10.1111/bjh.17821. Epub 2021 Sep 6. Br J Haematol. 2022. PMID: 34490627 Free PMC article. No abstract available.
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.
Sacconi A, De Vitis C, de Latouliere L, di Martino S, De Nicola F, Goeman F, Mottini C, Paolini F, D'Ascanio M, Ricci A, Tafuri A, Marchetti P, Di Napoli A, De Biase L, Negro A, Napoli C, Anibaldi P, Salvati V, Duffy D, Terrier B, Fanciulli M, Capalbo C, Sciacchitano S, Blandino G, Piaggio G, Mancini R, Ciliberto G. Sacconi A, et al. Among authors: di martino s, di napoli a. Cell Death Dis. 2021 Oct 29;12(11):1019. doi: 10.1038/s41419-021-04299-y. Cell Death Dis. 2021. PMID: 34716309 Free PMC article.
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
Bruschini S, Pallocca M, Sperandio E, D'Ambrosio L, Ascenzi F, De Vitis C, Salvati V, Esposito A, Di Martino S, De Nicola F, Paolini F, Fattore L, Alessandrini G, Facciolo F, Foddai ML, Bassi M, Venuta F, D'Ascanio M, Ricci A, D' Andrilli A, Napoli C, Aurisicchio L, Fanciulli M, Rendina EA, Ciliberto G, Mancini R. Bruschini S, et al. Among authors: di martino s. J Immunother Cancer. 2022 May;10(5):e004239. doi: 10.1136/jitc-2021-004239. J Immunother Cancer. 2022. PMID: 35584864 Free PMC article.
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.
Donzelli S, Cioce M, Sacconi A, Zanconato F, Daralioti T, Goeman F, Orlandi G, Di Martino S, Fazio VM, Alessandrini G, Telera S, Carosi M, Ciliberto G, Botti C, Strano S, Piccolo S, Blandino G. Donzelli S, et al. Among authors: di martino s. Mol Cancer. 2022 Jul 22;21(1):152. doi: 10.1186/s12943-022-01617-6. Mol Cancer. 2022. PMID: 35869553 Free PMC article. No abstract available.
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
Ruggiero CF, Fattore L, Terrenato I, Sperati F, Salvati V, Madonna G, Capone M, Valenti F, Di Martino S, Mandoj C, Liguoro D, Castaldo V, Cafaro G, Simeone E, Vanella V, Russillo M, Conti L, Cuda G, Giannarelli D, Ascierto PA, Mancini R, Ciliberto G. Ruggiero CF, et al. Among authors: di martino s. Theranostics. 2022 Oct 24;12(17):7420-7430. doi: 10.7150/thno.77761. eCollection 2022. Theranostics. 2022. PMID: 36438490 Free PMC article.
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
Laquintana V, Mottini C, Marchesi F, Marcozzi B, Terrenato I, Sperandio E, de Latouliere L, Carrieri F, Pimpinelli F, Pontone M, Pellini R, Campo F, Conti L, Accetta C, Mandoj C, Petrone F, Di Bella O, Vujovic B, Morrone A, Compagnone M, Principato E, Pinto E, Papa E, Falcucci P, La Malfa A, Pallocca M, De Marco F, Piaggio G, Ciliberto G, Mengarelli A, di Martino S. Laquintana V, et al. Among authors: di martino s. Front Immunol. 2024 Jan 26;14:1221587. doi: 10.3389/fimmu.2023.1221587. eCollection 2023. Front Immunol. 2024. PMID: 38343436 Free PMC article.
Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells.
Ascenzi F, Esposito A, Bruschini S, Salvati V, De Vitis C, De Arcangelis V, Ricci G, Catizione A, di Martino S, Buglioni S, Bassi M, Venuta F, De Nicola F, Massacci A, Grassucci I, Pallocca M, Ricci A, Fanciulli M, Ciliberto G, Mancini R. Ascenzi F, et al. Among authors: di martino s. Cell Death Dis. 2024 Apr 29;15(4):303. doi: 10.1038/s41419-024-06667-w. Cell Death Dis. 2024. PMID: 38684666 Free PMC article.
138 results